A SCAM by the Multi-National "Big PHARMA" INDUSTRY - PROFESSOR FROM BERKELEY COLLEAGUE SAYS: People do not die of cancer! People die of chemotherapy and in terrible pain!!!

“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. This is something you will not hear in the mass media that will continue to spread the myth that chemotherapy is the best medicine to fight cancer! ”

I've been saying this for years!

  PROFESSOR FROM BERKELEY COLLEAGUE SAYS: People do not die of cancer! 

After 25 years of studying people with cancer a professor came to a horrifying conclusion!

People die of chemotherapy and in terrible pain!!!

http://elixirvitaesecrets.com/142/horrifying-proffesor-from-berkeley-colleage-says-people-do-not-die-of-cancer-people-die-of-chemotherapy-and-in-terrible-pain/ 

The Cancer Industry is as much as it attempts to deny just that: only an industry! Doctors , pharmaceutical companies , hospitals , and other key stakeholders of the industry profit every time a patient agrees to conventional treatment , which usually involves injecting chemotherapy toxins into the body , blasting the body with ionizing radiation or cutting off parts of the body and in some barbaric cases combination of all three . It is little known that the science is covering or ignoring this, despite the fact that the medical industry claims, chemotherapy just does not work in the fight against cancer .
Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, has studied the life expectancy of cancer patients more than 25 years, when he came to the conclusion that, despite popular belief, chemotherapy does not work.
He testified that most of the cancer patients treated with chemotherapy die a horrible death. Also Dr. Jones warns that patients treated with chemotherapy die much faster and more painful than many other patients who have selected different treatment. After a great research he came to the conclusion that chemotherapy shortens the life and actually kills patients faster, and that is deliberately kept as secret because billions of dollars are in the game that cancer “industry ” turns over in their death networks.
The answer is that they are not really lying-just bending the truth a little. In other words, they merely adjust the method of gathering and evaluating statistics so as to guarantee the desired results. In the words of Dr. Hardin Jones:
       Evaluation of the clinical response of cancer to treatment by surgery and radiation, separately or in combination, leads to the following findings:
       The evidence for greater survival of treated groups in comparison with untreated is biased by the method of defining the groups. All reported studies pick up cases at the time of origin of the disease and follow them to death or end of the study interval. If persons in the untreated or central group die at any time in the study interval, they are reported as deaths in the control group. In the treated group, however, deaths which occur before completion of the treatment are rejected from the data, since these patients do not then meet the criteria established by definition of the term "treated." The longer it takes for completion of the treatment, as in multiple step therapy, for example, the worse the error.... With this effect stripped out, the common malignancies show a remarkably similar rate of demise, whether treated or untreated.

 From JAMA -( Medical Professionals ONLY Access)

Breast cancer is the most frequently diagnosed cancer in women, representing 31% of new

cancer cases, and the second most common cause of cancer death in women. Despite major

advances in early detection and therapy over the past 60 years, these death rates have been
remarkably resistant to change.

Many have argued that breast cancer screening efforts should include younger women,

particularly those 40 to 49 years of age. The evidence supporting the effectiveness of screening

in this age group, however, has not been as convincing as it is in older women, 50 to 74 years of

age. This has led to both widespread uncertainty about such efforts and confusion in the minds of

younger women and their physicians about whether or not to participate in screening.

This informational report reviews the reasons for the ongoing controversy about efforts to screen

women 40 to 49 years of age for breast cancer, including limitations of the existing randomized

controlled trials, possible reasons for lower effectiveness of screening in younger women, and

issues in using available data for policy-making.

A younger woman considering mammographic screening should understand: (1) her probability of

breast cancer; (2) the potential for a false-positive mammogram requiring further workup; (3) the

potential for a false-negative mammogram (and the need not to delay further care if a lump is
felt); (4) the potential for overtreatment for ductal carcinoma in situ (DCIS); and (5) the probability

of extending her life through mammography. 

As Dr. Hardin Jones revealed:
Beginning in 1940, through redefinition of terms, various questionable grades of malignancy were classed as cancer. After that date, the proportion of "cancer" cures having "normal" life expectancy increased rapidly, corresponding to the fraction of question-able diagnoses included.

“People who refused chemotherapy treatment live an average of 12 and a half years longer than the people who are receiving chemotherapy,” said Dr. Jones in his study, which was published in the journal of the New York Academy of Sciences. People who accepted chemotherapy die within three years of diagnosis, and many die quickly after a few weeks.”
“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. This is something you will not hear in the mass media that will continue to spread the myth that chemotherapy is the best medicine to fight cancer! ”
A separate study published in the Journal of the American Medical Association in 1979 discovered that many of the most common methods for diagnosing and treating breast cancer, of which nearly all are still used today, did nothing to reduce the rate of breast cancer or to increase the survival of patients with breast cancer. Two other studies, one from Israel published in 1978, and the other from Britain, which was published in The Lancet in 1980, came up with similar findings. “Overall survival of patients with primary breast cancer has not improved in the past 10 years , despite the increased use of multi- dose chemotherapy for treatment of metastasis ,” explains study Lancet , entitled “The failure of chemotherapy in the survival of patients with metastatic breast cancer. ”
“The carefully hidden truth is that many people who “died of cancer“ actually have died from treatment that included chemotherapy or radiation. Chemotherapy works by killing healthy cells in the body before they destroy the cancer that can develop very slow and in some natural ways even stop and restrain.

Most patients who have “died of cancer” actually have died of malnutrition, because cancerous cells take nutrients from the blood and destroy the immune system so the weakened body is liable to many infections against which is no longer able to defend itself.
Modern medicine has at its disposal a panacea, and the truth about cancer is skillfully hidden. This is because the price of a single treatment today costs 300,000-1,000,000$. “The majority of cancer patients die of chemotherapy. Chemotherapy does not remove breast cancer, colon cancer, or lung cancer. This fact has been documented more than ten years, but doctors still stubbornly use chemotherapy for these tumors “(Allen Levin, MD UCSF,” The Healing of Cancer).
A German epidemiologist at the “Mannheim Tumor Clinic” in Heidelberg, Dr. Ulrich Abel, did an extensive research and analysis of every major study and clinical application of chemotherapy ever undertaken in the world.